Molecular diagnostics market insights of market share analysis and analysis of each segment separately.

The global molecular diagnostics market generated $9.54 billion in 2017, in terms of value. The North America market holds a 46.29% share of the global molecular diagnostics market. The global molecular diagnostics market is expected to reach $29.68 billion by 2028, growing at a healthy CAGR of 10.89% during the forecast period between 2018-2028.

Major factors driving this growth include:

High Prevalence of Infectious Diseases and Various Types of Cancers
Growth in the Biomarker Identification Market and Advancements in Molecular Techniques
Increase in Awareness and Acceptance of Personalized Medicines
Significant External Funding for Executing Research and Development Exercises

Visit:

Comments

Understanding How the Human Centric Lighting Market is Segmented

Lighting plays a significant role in the lives of people, it has the potential to bring about positive changes in people’s behaviour. In the year 1989, a research was carried out and it proved that natural daylight can trigger the production of melatonin and serotonin, two of the most important hormones in the human body. These two hormones are responsible for inducing peaceful sleep and happiness in people. This led to the research and development in the field of human centric lighting (HCL). According to a report published by the BIS Research , the HCL market is expected to grow at a CAGR of 37.2% and 35.2% both in terms of volume and value during the forecast period (2018 – 2024). The HCL is segmented by the component, end-user and by region. Request the Sample: Human Centric Lighting Market The human centric lighting market can be further segmented by component, type, end-users, and region. The components or the controls are further segmented as microprocessors & microco...

Liquid Biopsy, North America, and Lung Cancer Occupying a Major Share in the Market

Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...

Global Surgical Robotics Market: Analysis and Forecast, 2018-2025

Global Surgical Robotics Market: Focus on Products and Services (Surgical Systems, Instruments & Accessories, and Services & Maintenance), Applications, End Users, and Competitive Landscape: Analysis and Forecast, 2018-2025. Rising incidences of colorectal cancer, neurological disorders, interventional cardiology disorders and gynecological diseases, growing geriatric population, and active participation of the government and the industry players in the technological advancement in the field of computer assisted robotic surgeries have boosted the overall growth of this market. Another factor which significantly contributes to the revenue generation of a company is the recurring sale of equipment and accessories of a surgical system. The surgical robotics vendors generate revenue through one time sale of the surgical system and generate the recurring revenue from the sale of equipment and accessory products and maintenance services used in the surgical system. A...

BIS Research ( Business Intelligence and Strategy Research)

Search This Blog